Boston Scientific Conference Presentation 2016

Boston Scientific Corporation's CFO Daniel Brennan discusses the company's strong 2016 performance, including 9% organic revenue growth and significant operating margin expansion. The presentation covers growth drivers across balanced divisions, emerging markets, and international regions, with positive outlook for future years.